Given the preliminary evidence of the suppressive effect of QDN on various biological behaviours of lung cancer cells and the apoptosis induction, as well as the upregulation of p53, we assumed that QDN plays a regulatory role in NSCLC through p53 activation. The gene discussed is TP53; the disease is non-small cell lung carcinoma.